Clinical trials / Pennsylvania

Psychedelic and ketamine trials recruiting in Pennsylvania

5 trials registered on ClinicalTrials.gov were recruiting at one or more sites in Pennsylvania on 26 Oct 2026. By substance: Psilocybin 3, Ketamine / esketamine 2. By condition: depression 3, opioid use disorder 2, anxiety 1, ocd 1.

From the ClinicalTrials.gov registry (US National Library of Medicine), read through its public API on 26 Oct 2026: studies marked as recruiting whose interventions name the substance. Titles, sponsors, phases, conditions and sites are the registry's own entries, written by the sponsors. We have not vetted any trial, and recruiting status changes; the registry record and the study team have the current eligibility rules.